Patients with gynecologic cancers who have Medicaid coverage are more likely to feel increased financial distress, anxiety about their cancer, and increased general anxiety during the pandemic if their annual income is less than $40,000, according to a new study from Weill Cornell Medicine investigators.
A study, published in Mayo Clinic Proceedings, demonstrates that Cologuard (mt-sDNA) is the most cost-effective colorectal cancer screening option in the Alaska Native population, as compared to colonoscopy and the fecal immunochemical test, for a wide range of adherence scenarios.
Concerns about fertility often influence how young women with breast cancer approach treatment decisions and are a reason for forgoing or delaying hormone-blocking therapy, a new study by Dana-Farber Cancer Institute investigators shows.
The American College of Radiology Data Science Institute and the Cancer Imaging Archive, funded by NCI, have teamed up to connect use cases and datasets to speed medical imaging artificial intelligence development.
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute have identified molecular patterns linked to patients developing resistance to certain therapies.
Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma.
Targeting a pathway that is essential for the survival of certain types of acute myeloid leukaemia could provide a new therapy avenue for patients, researchers from Wellcome Sanger Institute found.
Roswell Park Comprehensive Cancer Center and University of Rochester’s Wilmot Cancer Institute received a $2.08 million grant from NCI to research whether Black and white cancer patients respond differently to immune checkpoint inhibitors.
City of Hope scientists have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma.
Yale Cancer Center researchers have discovered a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases acute lymphoblastic leukemia, chronic lymphocytic leukemia, and Mantle cell lymphoma.